Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

ATHN Transcends Hemophilia Natural History Arm: Baseline Characteristics, Adverse Events, and Self-Reported Health Status of Individuals with Hemophilia A and B

Fernando F Corrales-Medina, Nana Ama Afari-Dwamena, Amanda B. Blair, Shannon L Carpenter, Tammuella Chrisentery-Singleton, Nabil Daoud, Maissaa Janbain, Leslie Raffini, Jonathan Schwartz, Ayesha Zia, Michael Recht

Blood (2024) 144 (Supplement 1): 1204.

https://doi.org/10.1182/blood-2024-198548

Published: 2024

Journal Articles

Indirect Comparison of the Efficacy and Therapy-Related Costs of a Pharmacokinetic and Individualized Prophylaxis Regimen with Simoctocog Alfa Versus Other Extended-Half Life Factor VIII Concentrates

Craig Kessler, Fernando F Corrales-Medina, Pier Mannuccio Mannucci, Michael D Tarantino

Blood (2024) 144 (Supplement 1): 2592.

https://doi.org/10.1182/blood-2024-193880

Published: 2024

Journal Articles

Characterization of Joint Disease in Women with Hemophilia: The Carriers Ultrasound Project (CUP) Study

Rachel S. Kronenfeld, Kelli Fraga, Maria D'Almeida Bastos, Amina Rafique, Christine Kempton, Joanna Davis, Fernando F Corrales-Medina

Blood (2023) 142 (Supplement 1): 29.

https://doi.org/10.1182/blood-2023-172662

Published: 2023

Journal Articles

Matching-Adjusted Indirect Comparison between Personalized Prophylaxis with Simoctocog Alfa Versus Standard Prophylaxis with Emicizumab in Adults with Hemophilia a

Craig Kessler, Fernando F Corrales-Medina, Pier Mannuccio Mannucci, Michael D. Tarantino

Blood (2023) 142 (Supplement 1): 5482.

https://doi.org/10.1182/blood-2023-180634

Published: 2023

Journal Articles

Matching-Adjusted Indirect Comparison of Personalized Prophylaxis with Simoctocog Alfa Versus Standard Prophylaxis with Efanesoctocog Alfa in Adults with Severe Hemophilia a

Craig Kessler, Fernando F Corrales-Medina, Pier Mannuccio Mannucci, Michael D. Tarantino

Blood (2023) 142 (Supplement 1): 5473.

https://doi.org/10.1182/blood-2023-180603

Published: 2023

Journal Articles

Athn 15: Characterizing the Real-World Use of Direct Oral Anticoagulants in Pediatric Patients - Interim Analysis

Jennifer G. Davila, MD, Fernando F. Corrales-Medina, MD, Dunlei Cheng, PhD, Leslie J. Raffini, MD, Courtney D Thornburg, MD, Crystal Watson, BS

Blood (2020) 136 (Supplement 1): 19–20.

https://doi.org/10.1182/blood-2020-137113

Published: 2020

Journal Articles

Emicizumab-Kxwh for Previously Untreated Patients with Haemophilia: The Conversation Begins

Tiffany Lin Lucas, MD, Shveta Gupta, MBBS, Joanna A. Davis, MD, Fernando F. Corrales-Medina, MD

Blood (2019) 134 (Supplement_1): 2409.

https://doi.org/10.1182/blood-2019-127270

Published: 2019

Journal Articles

Characterizing the Use of Direct Oral Anticoagulants in Children Using the American Thrombosis and Hemostasis Network Dataset (ATHNdataset)

Jennifer G. Davila, MD, Dunlei Cheng, PhD, Leslie J. Raffini, MD, Courtney D. Thornburg, MD, Fernando F. Corrales-Medina, MD

Blood (2019) 134 (Supplement_1): 1156.

https://doi.org/10.1182/blood-2019-128324

Published: 2019

Journal Articles

Uncovering Cardioprotective Strategies For Anthracycline Therapy By Analysis Of Redox and Apoptotic Effects

Daniela E. Egas Bejar, M.D., Joy M. Fulbright, M.D., Fernando F. Corrales-Medina, M.D., Mary E. Irwin, Ph.D., Blake Johnson, M.S., Joya Chandra, Ph.D.

Blood (2013) 122 (21): 1293.

https://doi.org/10.1182/blood.V122.21.1293.1293

Published: 2013

Journal Articles

Unique Apoptotic Effects Of Panobinostat and Marizomib In Acute Myeloid Leukemia and Bortezomib-Resistant Models

Fernando F. Corrales-Medina, M.D., Daniela E. Egas Bejar, M.D., Christa Manton, B.S., Blake Johnson, M.S., Mary E Irwin, Ph.D., Robert Z. Orlowski, M.D., Ph.D., Joya Chandra, Ph.D.

Blood (2013) 122 (21): 3837.

https://doi.org/10.1182/blood.V122.21.3837.3837

Published: 2013

Journal Articles

Cerebral Sinovenous Thrombosis Related to Iron Deficiency Anemia As a Result of Severe Menorrhagia: A Case Report

Fernando F. Corrales-Medina, MD, Nidra Rodriguez, MD, Daniela E Egas-Bejar, MD, Zoila Valdivia-Ascuna, MD, Leon Grant, MD, Pedro Mancias, MD

Blood (2012) 120 (21): 5143.

https://doi.org/10.1182/blood.V120.21.5143.5143

Published: 2012

NARROW

ATHN Transcends Hemophilia Natural History Arm: Baseline Characteristics, Adverse Events, and Self-Reported Health Status of Individuals with Hemophilia A and B

Indirect Comparison of the Efficacy and Therapy-Related Costs of a Pharmacokinetic and Individualized Prophylaxis Regimen with Simoctocog Alfa Versus Other Extended-Half Life Factor VIII Concentrates

Characterization of Joint Disease in Women with Hemophilia: The Carriers Ultrasound Project (CUP) Study

Matching-Adjusted Indirect Comparison between Personalized Prophylaxis with Simoctocog Alfa Versus Standard Prophylaxis with Emicizumab in Adults with Hemophilia a

Matching-Adjusted Indirect Comparison of Personalized Prophylaxis with Simoctocog Alfa Versus Standard Prophylaxis with Efanesoctocog Alfa in Adults with Severe Hemophilia a

Athn 15: Characterizing the Real-World Use of Direct Oral Anticoagulants in Pediatric Patients - Interim Analysis

Emicizumab-Kxwh for Previously Untreated Patients with Haemophilia: The Conversation Begins

Characterizing the Use of Direct Oral Anticoagulants in Children Using the American Thrombosis and Hemostasis Network Dataset (ATHNdataset)

Uncovering Cardioprotective Strategies For Anthracycline Therapy By Analysis Of Redox and Apoptotic Effects

Unique Apoptotic Effects Of Panobinostat and Marizomib In Acute Myeloid Leukemia and Bortezomib-Resistant Models

Cerebral Sinovenous Thrombosis Related to Iron Deficiency Anemia As a Result of Severe Menorrhagia: A Case Report

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only